Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VCAM1 | P19320 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | THRA | P10827 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6329382 | 0.94 | ALDH1A1 (0.39) | ALDH1A1NPSR1L3MBTL1KDM4EMAPT | |
| SCHEMBL6332543 | 0.91 | ALDH1A1 (0.40) | ALDH1A1NPSR1L3MBTL1KDM4EMAPT | |
| SCHEMBL6332395 | 0.85 | KMT2A (0.46) | ALDH1A1L3MBTL1KDM4EMAPTMAPK1 | |
| SCHEMBL6330135 | 0.82 | KMT2A (0.43) | ALDH1A1L3MBTL1KDM4EKMT2AGAA | |
| SCHEMBL6337102 | 0.80 | NOS2 (0.50) | ALDH1A1KMT2AMEN1HPGD | |
| Fumaric Acid SCHEMBL6332308 | 0.80 | NOS2 (0.50) | ALDH1A1L3MBTL1KDM4EMAPTTDP1 | |
| Fumaric Acid SCHEMBL6332303 | 0.80 | NOS2 (0.50) | ALDH1A1L3MBTL1KDM4EMAPTTDP1 | |
| SCHEMBL6338041 | 0.80 | NOS2 (0.48) | VCAM1ALDH1A1NPSR1L3MBTL1MAPT | |
| SCHEMBL6329391 | 0.78 | KMT2A (0.40) | ALDH1A1L3MBTL1KDM4EMAPTTDP1 | |
| SCHEMBL6338273 | 0.78 | KMT2A (0.46) | ALDH1A1KDM4EMAPTMAPK1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6900243-B2 | Phenylheteroalkylamine derivatives | ASTRAZENECA AB (SE) | 2005-05-31 | — | — | US | disclosed |
| EP-1263715-B1 | NOVEL PHENYLHETEROALKYLAMINE DERIVATIVES | ASTRAZENECA AB (SE) | 2004-04-28 | — | — | EP | disclosed |
| US-20030065174-A1 | Novel phenylheteroalkylamine derivatives | ASTRAZENECA AB (SE) | 2003-04-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030065174-A1 | Novel phenylheteroalkylamine derivatives | OPRK1, NOS2, OPRM1 | VCAM1 378/4885ALDH1A1 724/4885NPSR1 198/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.